Search

Your search keyword '"Pulitzer, Melissa"' showing total 677 results
Start Over Author "Pulitzer, Melissa"
677 results on '"Pulitzer, Melissa"'

1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., de Oliveira Araujo, Iguaracyra Barreto, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Di Napoli, Arianna, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr, Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Suzuki, Ritsuro, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2023
Full Text
View/download PDF

2. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis

Author

Mark, Erica, Kempf, Werner, Guitart, Joan, Pulitzer, Melissa, Mitteldorf, Christina, Hristov, Alexandra, Torres-Cabala, Carlos, Marchi, Enrica, Cropley, Thomas, Rodriguez Pinilla, Socorro Maria, Griffin, Teresa, Fernandez, Rony, Pileri, Stefano, Pileri, Alessandro, Tabanelli, Valentina, Borretta, Lisa, Subtil, Antonio, Plaza, Jose Antonio, Piris, Jose A. Miguel Angel, Feldman, Andrew L., Cerroni, Lorenzo, and Gru, Alejandro A.

Published
2024
Full Text
View/download PDF

3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D, Araujo, Iguaracyra Barreto de Oliveira, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John KC, Cheuk, Wah, Chng, Wee-Joo, Choi, John K, Chuang, Shih-Sung, Coupland, Sarah E, Czader, Magdalena, Dave, Sandeep S, de Jong, Daphne, Du, Ming-Qing, Elenitoba-Johnson, Kojo S, Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J, Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M, Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E, Kumar, Shaji, Lazar, Alexander J, Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S, Liu, Wei-Ping, Louissaint, Abner, Marcogliese, Andrea, Medeiros, L Jeffrey, Michal, Michael, Miranda, Roberto N, Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N, Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S Vincent, Rawstron, Andrew C, Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D, Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Subjects
Cancer, Hematologic Neoplasms, Humans, Lymphoma, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.

Published
2022

10. In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response

Author

Sahu, Aditi, Kose, Kivanc, Kraehenbuehl, Lukas, Byers, Candice, Holland, Aliya, Tembo, Teguru, Santella, Anthony, Alfonso, Anabel, Li, Madison, Cordova, Miguel, Gill, Melissa, Fox, Christi, Gonzalez, Salvador, Kumar, Piyush, Wang, Amber Weiching, Kurtansky, Nicholas, Chandrani, Pratik, Yin, Shen, Mehta, Paras, Navarrete-Dechent, Cristian, Peterson, Gary, King, Kimeil, Dusza, Stephen, Yang, Ning, Liu, Shuaitong, Phillips, William, Guitera, Pascale, Rossi, Anthony, Halpern, Allan, Deng, Liang, Pulitzer, Melissa, Marghoob, Ashfaq, Chen, Chih-Shan Jason, Merghoub, Taha, and Rajadhyaksha, Milind

Published
2022
Full Text
View/download PDF

11. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy

Author

Friedman, Joshua S., primary, Durham, Benjamin H., additional, Reiner, Anne S., additional, Yabe, Mariko, additional, Petrova‐Drus, Kseniya, additional, Dogan, Ahmet, additional, Pulitzer, Melissa, additional, Busam, Klaus J., additional, Francis, Jasmine H., additional, Rampal, Raajit K., additional, Ulaner, Gary A., additional, Reddy, Ryan, additional, Yeh, Randy, additional, Hatzoglou, Vaios, additional, Lacouture, Mario E., additional, Rotemberg, Veronica, additional, Mazor, Roei D., additional, Hershkovitz‐Rokah, Oshrat, additional, Shpilberg, Ofer, additional, Goyal, Gaurav, additional, Go, Ronald S., additional, Abeykoon, Jithma P., additional, Rech, Karen, additional, Morlote, Diana, additional, Fidai, Shiraz, additional, Gannamani, Vedavyas, additional, Zia, Maryam, additional, Abdel‐Wahab, Omar, additional, Panageas, Katherine S., additional, Rosenblum, Marc K., additional, and Diamond, Eli L., additional

Published
2024
Full Text
View/download PDF

16. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

Author

Guitart, Joan, Martinez-Escala, M Estela, Subtil, Antonio, Duvic, Madeleine, Pulitzer, Melissa P, Olsen, Elise A, Kim, Ellen, Rook, Alain H, Samimi, Sara S, Wood, Gary S, Girardi, Michael, Junkins-Hopkins, Jacqueline, Ivan, Doina S, Selim, M Angelica, Sable, Kimberly A, Virmani, Pooja, Pincus, Laura B, Tetzlaff, Michael T, Kim, Jinah, and Kim, Youn H

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Rare Diseases, Clinical Research, Clinical Trials and Supportive Activities, Hematology, Lymphoma, Cancer, Adult, Aged, Aged, 80 and over, Female, Humans, Lymphoma, T-Cell, Cutaneous, Male, Middle Aged, Skin Neoplasms, T-Lymphocytes, Cytotoxic, World Health Organization, Young Adult, Medical and Health Sciences, Pathology, Clinical sciences
Abstract

Primary cutaneous CD8-positive aggressive epidermotropic T-cell lymphoma is a rare and poorly characterized variant of cutaneous lymphoma still considered a provisional entity in the latest 2016 World Health Organization Classification of Cutaneous lymphomas. We sought to better characterize and provide diagnostic and therapeutic guidance of this rare cutaneous lymphoma. Thirty-four patients with a median age of 77 years (range 19-89 years) presented primarily with extensive annular necrotic plaques or tumor lesions with frequent mucous membrane involvement. The 5-year survival was 32% with a median survival of 12 months. A subset of 17 patients had a prodrome of chronic patches prior to the development of aggressive ulcerative lesions. We identified cases with lack of CD8 or αβ T-cell receptor expression yet with similar clinical and pathological presentation. Allogeneic stem cell transplantation provided partial or complete remissions in 5/6 patients. We recommend the term primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphoma as this more broad designation better describes this clinical-pathologic presentation, which allows the inclusion of cases with CD8 negative and/or αβ/γδ T-cell receptor chain double-positive or double-negative expression. We have identified early skin signs of chronic patch/plaque lesions that are often misdiagnosed as eczema, psoriasis, or mycosis fungoides. Our experience confirms the poor prognosis of this entity and highlights the inefficacy of our standard therapies with the exception of allogeneic stem cell transplantation in selected cases.

Published
2017

17. Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience.

Author

Cowen, Emily A., Barrios, Dulce M., Pulitzer, Melissa P., Moy, Andrea P., Dusza, Stephen W., De Wolf, Susan, Geyer, Mark B., and Markova, Alina

Subjects
SWEET'S syndrome, CHRONIC leukemia, ACUTE myeloid leukemia, MYELODYSPLASTIC syndromes, MYELOPROLIFERATIVE neoplasms
Abstract

Introduction: Sweet syndrome (SS) is well known to be associated with underlying hematologic malignancies. The incidence and qualities of SS among novel targeted therapies for acute myeloid leukemia (AML) have not yet been described. Methods: Through retrospective review of 19,432 patients diagnosed with acute/chronic leukemia or myelodysplastic syndromes/myeloproliferative neoplasms (MDS+/−MPN) over 28 years, we calculated the incidence of SS in the setting of select hematologic malignancies and described the clinicopathologic characteristics of SS in patients with onset of SS after initiation of novel AML-targeted therapies. Results: Overall incidence of SS was 0.36% (95% CI: 0.27–0.45%), which was significantly higher among patients with AML (50/5,248, 0.94%; 95% CI: 0.71–1.25%). Nine AML patients were on 4 classes of novel targeted treatments – IDH1/2 inhibitor alone, FLT3 inhibitor, IDH2 and DOT1L inhibitor, and anti-CD33 therapy. In therapies inducing myeloid blast differentiation, SS occurred at later onset following treatment. Conclusions: In AML patients with fever and unusual skin lesions, physicians may consider SS earlier, which may shorten time to diagnosis. Future assessments of SS among patients treated with novel therapies for AML and molecular studies of biopsies may help further explain this dermatologic adverse event with earlier diagnosis and management of neutrophilic dermatoses in these patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Jejunal adenocarcinoma with cutaneous metastasis

Author

Chung, Esther, Syklawer, Ericka, Pulitzer, Melissa P, Marchetti, Michael A, Querfeld, Christiane, and Myskowski, Patricia L

Subjects
Cutaneous metastasis, jejunal adenocarcinoma
Abstract

Small bowel adenocarcinoma (SBA) is a rare primary gastrointestinal malignancy. We present a 60-year old man who developed a cutaneous metastasis of jejunal adenocarcinoma to his neck. This case highlights the clinicopathologic and immunophenotypic features of this uncommon cutaneous metastasis.

Published
2015

34. Supplemental Data from Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Author

Ariyan, Charlotte E., primary, Brady, Mary Sue, primary, Siegelbaum, Robert H., primary, Hu, Jian, primary, Bello, Danielle M., primary, Rand, Jamie, primary, Fisher, Charles, primary, Lefkowitz, Robert A., primary, Panageas, Kathleen S., primary, Pulitzer, Melissa, primary, Vignali, Marissa, primary, Emerson, Ryan, primary, Tipton, Christopher, primary, Robins, Harlan, primary, Merghoub, Taha, primary, Yuan, Jianda, primary, Jungbluth, Achim, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Rudensky, Alexander Y., primary, Wolchok, Jedd D., primary, and Allison, James P., primary

Published
2023
Full Text
View/download PDF

35. Data from Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Author

Ariyan, Charlotte E., primary, Brady, Mary Sue, primary, Siegelbaum, Robert H., primary, Hu, Jian, primary, Bello, Danielle M., primary, Rand, Jamie, primary, Fisher, Charles, primary, Lefkowitz, Robert A., primary, Panageas, Kathleen S., primary, Pulitzer, Melissa, primary, Vignali, Marissa, primary, Emerson, Ryan, primary, Tipton, Christopher, primary, Robins, Harlan, primary, Merghoub, Taha, primary, Yuan, Jianda, primary, Jungbluth, Achim, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Rudensky, Alexander Y., primary, Wolchok, Jedd D., primary, and Allison, James P., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 2 from Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma

Author

Catalanotti, Federica, primary, Solit, David B., primary, Pulitzer, Melissa P., primary, Berger, Michael F., primary, Scott, Sasinya N., primary, Iyriboz, Tunc, primary, Lacouture, Mario E., primary, Panageas, Katherine S., primary, Wolchok, Jedd D., primary, Carvajal, Richard D., primary, Schwartz, Gary K., primary, Rosen, Neal, primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure Legend from Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma

Author

Catalanotti, Federica, primary, Solit, David B., primary, Pulitzer, Melissa P., primary, Berger, Michael F., primary, Scott, Sasinya N., primary, Iyriboz, Tunc, primary, Lacouture, Mario E., primary, Panageas, Katherine S., primary, Wolchok, Jedd D., primary, Carvajal, Richard D., primary, Schwartz, Gary K., primary, Rosen, Neal, primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 1B from Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma

Author

Catalanotti, Federica, primary, Solit, David B., primary, Pulitzer, Melissa P., primary, Berger, Michael F., primary, Scott, Sasinya N., primary, Iyriboz, Tunc, primary, Lacouture, Mario E., primary, Panageas, Katherine S., primary, Wolchok, Jedd D., primary, Carvajal, Richard D., primary, Schwartz, Gary K., primary, Rosen, Neal, primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 3 from Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma

Author

Catalanotti, Federica, primary, Solit, David B., primary, Pulitzer, Melissa P., primary, Berger, Michael F., primary, Scott, Sasinya N., primary, Iyriboz, Tunc, primary, Lacouture, Mario E., primary, Panageas, Katherine S., primary, Wolchok, Jedd D., primary, Carvajal, Richard D., primary, Schwartz, Gary K., primary, Rosen, Neal, primary, and Chapman, Paul B., primary

Published
2023
Full Text
View/download PDF

41. Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study

Author

Navarrete-Dechent, Cristian, primary, Cordova, Miguel, additional, Aleissa, Saud, additional, Liopyris, Konstantinos, additional, Dusza, Stephen W., additional, Kose, Kivanc, additional, Busam, Klaus J., additional, Hollman, Travis, additional, Lezcano, Cecilia, additional, Pulitzer, Melissa, additional, Chen, Chih-Shan J., additional, Lee, Erica H., additional, Rossi, Anthony M., additional, and Nehal, Kishwer S., additional

Published
2023
Full Text
View/download PDF

46. Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab.

Author

Parisi, Rose, Cowen, Emily A., Gu, Stephanie, Dusza, Stephen, Pulitzer, Melissa, Geyer, Mark B., King, Amber C., and Markova, Alina

Subjects
LYMPHOBLASTIC leukemia, ECZEMA, SEBORRHEIC dermatitis, T cells
Abstract

Patients with blinatumomab DAEs experience CRS, ICANS, and MRD-negative response as frequently as non-DAE patients. HT

CharacteristicAll patients on blinatumomab monotherapy (N = 45)Patients with DAE on blinatumomab monotherapya (N = 7)
Age, mean4 Fourteen patients on monotherapy had 18 DAEs; nine DAEs were determined to be unlikely related or unrelated to blinatumomab, three of these were irritant or allergic contact dermatitis to the infusion line securement antisepsis or dressings. [Extracted from the article]

Published
2023
Full Text
View/download PDF

49. Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma

Author

Gu, Lilly, primary, Lin, Erica, additional, Liu, Shuaitong, additional, Yang, Ning, additional, Kurtansky, Nicholas, additional, Neumann, Neil M., additional, Stoll, Joseph, additional, Lezcano, Cecilia, additional, Pulitzer, Melissa, additional, Noor, Sarah, additional, Markova, Alina, additional, Rossi, Anthony, additional, Dickson, Mark A., additional, and Deng, Liang, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results